1 / 27

Absorption

Absorption. Affected by physiological factors route of administration drug distribution drug chemical physical properties dissolution rate (solids) hydrophilicity/hydrophobicity. Pathways of Oral Absorption. Two main mechanisms of transport across the gastrointestinal membrane:

cathy
Télécharger la présentation

Absorption

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Absorption • Affected by • physiological factors • route of administration • drug distribution • drug chemical physical properties • dissolution rate (solids) • hydrophilicity/hydrophobicity CHEE 440

  2. Pathways of Oral Absorption Two main mechanisms of transport across the gastrointestinal membrane: Transcellular diffusion Paracellular diffusion CHEE 440

  3. Transcellular Diffusion The transcellular pathway is composed of 3 mechanisms: passive diffusion, carrier-mediated transport, endocytosis Passive diffusion CHEE 440

  4. Partition coefficient, Ko/w • for absorption into cell, drug must pass through lipid cell membrane • consider two immiscible phases (oil and water) and a drug which is soluble in both (ex. cyclosporine), at equilibrium. oil water ideal and ideally dilute solutions : CHEE 440

  5. Clinical Significance of Ko/w • prediction of absorption of drugs through various tissues • absorption of acidic drugs from colon • absorption of basic drugs from small intestine CHEE 440

  6. Partition Coefficient and Absorption Optimum Ko/w CHEE 440

  7. Carrier-Mediated Transport • Active transport CHEE 440

  8. Drug Solubility • Solubility: the extent to which a drug dissolves under a given set of conditions of solvent and temperature • significance • drugs must be in solution before they can be absorbed • drugs of low aqueous solubility present formulation problems • saturation concentration, Csat • limit of solubility of a solute in a solvent at a given T CHEE 440

  9. Csat C = Cb Dissolution Rate • important for tablets, capsules, suspensions • slow dissolution rate = low bioavailability • consider a solid particle in water stagnant water layer Noyes-Whitney Eqn CHEE 440

  10. Dissolution Rate • But, surface area changes with time; • for spherical particles: • for N particles: r = radius at time t ro= initial radius r = density M = mass of particles k = cube-root dissolution constant CHEE 440

  11. Factors influencing Csat • crystal structure: polymorphism, hydrates • pH • salt form • common ion effect • co-solvents CHEE 440

  12. crystal solid + solvent + dissolved solute Process of Dissolution CHEE 440

  13. Crystalline Solids • regular, ordered structure • composed of identical repeating units - unit cell • ex. cubic, rhombic, tetragonal • have distinct melting pts • strength of bonds between atoms, molecules determines : • geometry of unit cell • Tf, CHEE 440

  14. Crystalline Solids • Electrostatic, Covalent Bonds • ex. NaCl, graphite (C4) • strong bonds - cubic unit cell • hi Tf, hi (eg. Tf= 801°C for NaCl) • stable structure • hard, brittle CHEE 440

  15. Crystalline Solids • Van der Waals, H-bonds • ex. organic compounds • weak bonds • low Tf, low (e.g. Tf = 238°C for caffeine) • soft materials • metastable structures CHEE 440

  16. Polymorphism • molecule can crystallize into more than one crystal structure • metastable form transforms to stable form over time • usually nonreversible process - monotropic polymorphism • many polymorphic forms possible • progesterone - 2 • nicotinamide - 4 • dissolution rate changes with polymorphic form CHEE 440

  17. Amorphism • no crystal structure • no distinct Tf • supercooled liquids - subdued molecular motion • flow under an applied pressure • generally easier to dissolve CHEE 440

  18. Crystal Hydrates • solvent trapped when compound crystallizes - solvates • solvent is water - hydrates • no water - anhydrate • solvent-compound interactions • H2O further stabilizes lattice - polymorphic solvates • H2O occupies void spaces - pseudopolymorphic solvates CHEE 440

  19. Crystal Hydrates • anhydrate has higher Tf, generally dissolves faster CHEE 440

  20. Crystal Hydrates • Significance • incorporation of H2O affects bioabsorption rate and  bioactivity CHEE 440

  21. pH and solubility • weakly acidic drug • pHp  the pH below which the drug precipitates from solution • weakly basic drug • pHp  the pH above which the drug precipitates from solution CHEE 440

  22. Drug Salt Form • salt solubility depends on nature of counter-ion CHEE 440

  23. Slightly Soluble Electrolytes • ex. Al(OH)3, Ca2CO3, ZnO, drug salts AgCl(s) Ag+(L) + Cl-(L) Ksp = [Ag+] [Cl-] = 1.25(10-10) at 25°C Al(OH)3 Al3+(L) + 3OH-(L) Ksp = [Al3+] [OH-]3 = 7.7(10-13) at 25°C • beware of common ion effect (salting-out) CHEE 440

  24. Other solubility issues • cosolvents • solvents which, when combined, increase the solubility of a given compound • ex. phenobarbital in water has a solubility of 0.1g/100 ml, in alcohol 1 g in 10 ml, and in 20% alcohol/water 0.3 g/100 ml • combined effect of pH and cosolvent • adding alcohol to buffered solution of weak electrolyte increases solubility of undissociated form • decreases pHp for a weakly acidic drug CHEE 440

  25. pH and Ko/w • dissociated portion of drug does not dissolve in oil phase • partition coefficient • apparent partition coefficient CHEE 440

  26. pH and Ko/w • as change pH, add common ion, [HA]w changes weak acid : weak base : CHEE 440

  27. Summary • Absorption of drug is influenced by combination of permeability and solubility • Implications of Low Drug Permeability • incomplete absorption • rapid, complete dissolution needed • release may need to be modified • increase exposure to an absorption window • possible retarded release if a saturable transport phenomenon exists • Implications of Low Drug Solubility • will have to optimize particle size • consider salt forms, polymorphs, hydrates, co-solvents CHEE 440

More Related